Introduction
In our search for an orally active drug for the treatment of iron overload diseases, we have focused our attention on the Fe coordination chemistry of two series of ligands; the pyridylcarbaldehyde isonicotinoyl hydrazone (HPCIH) and isonicotinoyl picolinoyl hydrazine (H 2 IPH) analogues (Chart 1). Several ligands from each of these families have shown high in vitro activity in mobilizing Fe from 59 Fe-loaded cells and also in preventing Fe uptake from 59 Fe-labeled transferrin. 1, 2 Both series of ligands have been found to coordinate meridionally as tridentate chelators through the pyridyl (N), azomethine/amide (N) and carbonyl (O) groups. The HPCIH hydrazones are monobasic acids and coordinate typically in their monoanionic form, 3 while the H 2 IPH hydrazines bear two weakly acidic N-atoms and can coordinate in either their monoor dianionic forms. 2 These labile protons are highlighted in bold type in Chart 1.
In an earlier publication, we reported that complexation of Fe III or Fe II with HPCIH in aerated aqueous solution gave an unexpected and unprecedented Fe-catalysed oxidation of HPCIH to H 2 IPH, which was identified by isolation and structural characterisation of the complex Fe III (IPH)(HIPH). 2 This serendipitous observation initiated our interest in the H 2 IPH series, which has now emerged as an equally effective series of Fe chelators. Furthermore, we have found that the isonicotinoyl (4-pyridyl) N-atom enables HPCIH to act as a bridging ligand, with oligonuclear HPCIH complexes of Mn II , Co III and Zn II having been identified and characterised structurally. 3 The picolinoyl hydrazone HPCPH is isomeric with HPCIH, but the N-atom on the pyridyl ring adjacent to the carbonyl group is in a position where it may coordinate in a chelating mode in partnership with either the adjacent N-or O-donor of the amide group. As we illustrate in this study, the coordination mode of HPCPH is unique amongst members of the HPCIH family, but its Fe II complex is also susceptible to oxidation as seen for its isomer HPCIH.
Experimental
Syntheses HPCIH and HPCPH were prepared by Schiff base condensations between 2-pyridinecarbaldehyde and either isonicotinic and picolinic acid hydrazide, respectively, as described. (Fig. 1 ) revealing a dinuclear triple helical assembly, with each ligand coordinating in a bis-bidentate mode exclusively through its N-donors. The complex has crystallographic D 3 symmetry, but this is not an intrinsic property of the complex, which is in fact asymmetric (see below). The apparent symmetry is a consequence of disorder. The crystallographically unique carbonyl O-atom (O1) was refined at 2 /3 occupancy i.e. it is present on but four of the six symmetry-related atoms (C6) adjacent to each pyridyl ring as illustrated in Fig. 1 9, 10 In order to attain this triple helical conformation each ligand is twisted about the N-N bond (C6-N2-N2-C6 torsion angle of 80.8°). The crystallographically unique Fe-N2 bond length is representative of both Fe-NCH and Fe-N-CO groups due to the disorder found in the structure, and any differences in the actual NCH and N-CO bond lengths were not resolved. The intramolecular FeFe separation is 3.489(3) Å. Disordered water and MeCN molecules were also identified in the structure.
Asymmetry of the complex was established by NMR spectroscopy, where sharp signals were observed due to both metal centres existing in low-spin d 6 
Physical methods
Electronic spectra were recorded on a Perkin-Elmer Lambda 40 spectrophotometer, and IR spectra were obtained on a Perkin-Elmer 1600 Series FTIR spectrometer, with samples dispersed in KBr disks. Nuclear magnetic resonance spectra were recorded at 500 ( 1 H) and 125.8 MHz ( 13 C) on a Bruker Avance spectrometer using DMSO-d 6 as the solvent and TMS as the reference. Cyclic voltammetry was performed with a BAS100B/W electrochemical workstation employing glassy-carbon working electrode, a Pt auxiliary electrode and a non-aqueous Ag/Ag + (MeCN) reference electrode. Bulk electrolysis was carried out with a BAS reticulated vitreous carbon electrode. All solutions for electrochemistry contained ca. 2 mmol dm −3 analyte and 0.1 mol dm −3 n-Bu 4 NClO 4 in dry MeCN and were purged with nitrogen gas before measurement. Electron paramagnetic resonance spectra were recorded at 77 K on a Bruker ER200D spectrometer at X-band frequency (9.303 GHz). Samples were prepared as 1 mM solutions in MeCN. Spectra were simulated with the program EPR50F.
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Crystallography
Data were collected at 150 K with an Oxford 600 Series Cryostream Cooler attached to an Enraf Nonius CAD4 diffractometer. Cell constants were determined by a least-squares fits to the setting parameters of 25 independent reflections employing graphite-monochromated Mo-Ka radiation (0.71073 Å). Data reduction and empirical absorption correction (w-scans) were performed with the WinGX package. 6 The structure was solved by direct methods with SHELXS and refined by full-matrix leastsquares analysis with SHELXL. The MeCN solvent molecule was severely disordered about a three-fold rotation axis. Three unique positions were identified for this solvent molecule. One position has the molecule (N3A, C7A and C8A) coincident with a three-fold axis; another (N3B, C7B and C8B) finds only the nitrile carbon (C7B) on the three-fold axis, while the third (N3C, C7C and C8C) finds that only the N-atom on the three-fold axis. The occupancies were restrained to sum to one-third comprising a 1 : 1 ratio of Fe : MeCN, which is consistent with the NMR data obtained from the crystals. Restraints to the C-C and C-N bond lengths were necessary to enable refinement. The unique water molecule was disordered over two sites and the occupancies were refined complementarily (O2A : O2B 87 : 13%).
Crystal data
[Fe 2 (PCPH) 2 (Fig. 2(a) ). An identical result was achieved by combining one equivalent of FeCl 3 and two equivalents of HPCIH in MeCN, with two equivalents of Et 3 N added as base (Fig. 2(b) ). The spectrum is typical of a low-spin, axially symmetric Fe III complex 11 with g x = g y = 2.255 and g z = 1.935. The parameter g x = 1.935 is diagnostic of compounds with a d xy ground state, which usually exhibit one g value below 2. 12 Coordinate bond lengths of lowspin Fe II and low-spin Fe III complexes are generally very similar, and it is assumed that oxidation of the parent Fe II complex does not bring about a significant structural change.
Cyclic voltammetry of Fe II 2 (PCPH) 2 (PPH) in MeCN solution (Fig. 3) revealed two totally reversible Fe III/II couples at +28 mV and +507 mV vs Ag/Ag + . We propose that the lower potential couple of Fe II 2 (PCPH) 2 (PPH) corresponds to the Fe centre bearing the three coordinated amides, while the higher potential wave is due to the centre bearing two azomethine N-donors and only one amide. This assignment is based on the well-known ability of N-bound deprotonated amides to stabilise higher oxidation states. 13 The large separation (500 mV) between the two Fe III/II couples is further evidence for the asymmetric structure deduced from the NMR data i.e. the two metals are in different FeN 6 coordination environments and moreover distinct from Fe(PCIH) 2 (FeN 4 O 2 ) . The unexpected and interesting product Fe II 2 (PCPH) 2 (PPH) reported here provides the first example to our knowledge of an asymmetric, mixed-ligand, triple helicate. Three-fold symmetric helicates bearing identical ligands are the norm. [14] [15] [16] Stratton and Busch [17] [18] [19] originally synthesised the dinuclear Fe II complex [Fe 2 (PAA) 3 ]X 4 (PAA = 2-pyridinealdazine, X = I − or ClO 4 − ) and proposed, in the absence of crystallographic data, a (D 3 -symmetric) dinuclear triple helical structure. This is now credited as the first recognised example of a dinuclear triple helicate. This proposed structure was eventually confirmed by crystallographic work of Hannon and co-workers. 20 Other related systems that also form symmetrical triple helical di-Fe II complexes include [Fe 2 (PAHAP) 3 ](NO 3 ) 4 and its pyrazine analogue. 21 We have seen no other helical compounds of this type in our investigations of the coordination chemistry of the HPCIH and H 2 IPH analogues. 2, 3 In addition, none of the O-donors are coordinated in Fe II 2 (PCPH) 2 (PPH); a unique feature for both are predisposed to act as (hypodentate) bisbidentate chelates like the azine analogues PAA and PAHAP, and no other products were observed in the present synthesis, so assembly of this complicated structure must be rapid and highly favorable. Further work is needed to address the question of whether ligands such as HPCPH and H 2 PPH behave differently to the other related hydrazones and hydrazines of their respective families in the complexation and mobilisation of intracellular Fe.
